Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression
Psoriasis is a chronic immune-mediated disease, linked to local and systemic inflammation and predisposing patients to a higher risk of associated comorbidities. Cytokine levels are not widely available for disease progression monitoring due to high costs. Validated low-cost and reliable markers are...
Main Authors: | Oana Mirela Tiucă, Silviu Horia Morariu, Claudia Raluca Mariean, Robert Aurelian Tiucă, Alin Codrut Nicolescu, Ovidiu Simion Cotoi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/14/1/114 |
Similar Items
-
Predictive Performances of Blood-Count-Derived Inflammatory Markers for Liver Fibrosis Severity in Psoriasis Vulgaris
by: Oana Mirela Tiucă, et al.
Published: (2023-11-01) -
Research Hotspots in Psoriasis: A Bibliometric Study of the Top 100 Most Cited Articles
by: Oana Mirela Tiucă, et al.
Published: (2023-06-01) -
Cancer Cachexia: New Insights and Future Directions
by: Claudia Raluca Mariean, et al.
Published: (2023-11-01) -
Skin Cancer Correlations in Psoriatic Patients
by: Daniel Octavian Costache, et al.
Published: (2023-04-01) -
FACTORS ASSOCIATED WITH SEVERITY OF DISEASE IN PSORIATIC ARTHRITIS: A CROSS-SECTIONAL STUDY
by: Tania Gudu, et al.
Published: (2017-03-01)